Table 6.

Immunosuppressive and immunomodulatory therapy (n = 67)

Oral glucocorticoids	51 (76.1)
Intravenous glucocorticoids	18 (26.9)
MMF/mycophenolate sodium	19 (28.4)
Cyclophosphamide	9 (13.4)
Azathioprine	9 (13.4)
Plasma exchange	6 (9.0)
Hydroxychloroquine	6 (9.0)
Methotrexate	5 (7.5)
Dapsone	4 (6.0)
Tonsillectomy	4 (6.0)
Intravenous Ig	4 (6.0)
Rituximab	4 (6.0)
Alemtuzumab	3 (4.5)
Colchicine	3 (4.5)
Leflunomide	2 (3.0)
Bortezomib	1 (1.5)
Infliximab	1 (1.5)
Thalidomide	1 (1.5)

Values expressed as n (%).